Key regions: United Kingdom, Germany, France, South Korea, Italy
Despite the global pandemic, Turkmenistan has reported no cases of COVID-19, making it one of the few countries in the world with zero confirmed cases. This is largely due to the country's strict border controls and limited international travel. As a result, the COVID-19 vaccines market in Turkmenistan is not as prominent as in other countries in the region.
Customer preferences: Given the absence of COVID-19 cases in Turkmenistan, there is currently no demand for COVID-19 vaccines in the country. However, the government has expressed interest in acquiring vaccines for future use, should the need arise.
Trends in the market: The COVID-19 vaccines market in Turkmenistan is still in its infancy, with no vaccines currently available in the country. However, the government has reportedly expressed interest in acquiring vaccines from various sources, including Russia and China. It remains to be seen which vaccines the government will ultimately choose to purchase, and how the market will develop as a result.
Local special circumstances: Turkmenistan's strict border controls and limited international travel have helped to keep the country COVID-free, but they have also limited the availability of vaccines. The government's interest in acquiring vaccines suggests that they are preparing for the possibility of future outbreaks, but it is unclear how quickly vaccines will be made available to the general public.
Underlying macroeconomic factors: Turkmenistan's economy is heavily dependent on the export of natural gas, and the COVID-19 pandemic has had a significant impact on global energy markets. As a result, the government may be hesitant to spend large amounts of money on vaccines, especially if there is no immediate need for them. Additionally, Turkmenistan's authoritarian government has a history of downplaying public health concerns, which may also impact the country's approach to COVID-19 vaccines.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
